Michael Robinson

Summary

Affiliation: University of Sydney
Country: Australia

Publications

  1. ncbi request reprint Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis
    M Robinson
    Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia
    Pediatr Pulmonol 30:16-24. 2000
  2. ncbi request reprint Regional mucociliary clearance in patients with cystic fibrosis
    M Robinson
    Respiratory Investigation Unit, Royal Prince Alfred Hospital, Sydney, Australia
    J Aerosol Med 13:73-86. 2000
  3. ncbi request reprint Mucociliary clearance in cystic fibrosis
    Michael Robinson
    Cystic Fibrosis Centre E11S, Royal Prince Alfred Hospital, Missenden Road, Camperdown, New South Wales 2050, Australia
    Pediatr Pulmonol 33:293-306. 2002
  4. ncbi request reprint Glycosylation of sputum mucins is altered in cystic fibrosis patients
    Benjamin L Schulz
    Proteome Systems Ltd, Unit 1, 35 41 Waterloo Road, North Ryde, Sydney, NSW 2113, Australia
    Glycobiology 17:698-712. 2007
  5. ncbi request reprint A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis
    Mark R Elkins
    Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia
    N Engl J Med 354:229-40. 2006
  6. ncbi request reprint Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: a pilot study in a Sydney clinic
    Rajeev Soni
    Department of Respiratory Medicine, Gosford Hospital, Gosford, New South Wales, Australia
    Respirology 7:241-5. 2002
  7. pmc Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions
    Dominic Hill
    Department of Infectious Diseases and Immunology, University of Sydney, Sydney, Australia
    J Clin Microbiol 43:5085-90. 2005
  8. ncbi request reprint Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects
    Andrew J Sloane
    Proteome Systems Ltd, Unit 1, 35 41 Waterloo Road, North Ryde, Sydney, NSW 2113, Australia
    Am J Respir Crit Care Med 172:1416-26. 2005
  9. ncbi request reprint Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction
    Evangelia Daviskas
    Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia
    J Aerosol Med 15:331-41. 2002
  10. ncbi request reprint An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: application to cystic fibrosis
    Susanne K Pedersen
    Proteome Systems Ltd, 1 35 41 Waterloo Road, North Ryde, New South Wales 2113, Australia
    Mol Cell Proteomics 4:1052-60. 2005

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis
    M Robinson
    Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia
    Pediatr Pulmonol 30:16-24. 2000
    ..In conclusion, we were unable to demonstrate any improvements in either ciliary or cough clearance in response to a short course of rhDNase. The mechanism of action of this drug in vivo remains uncertain...
  2. ncbi request reprint Regional mucociliary clearance in patients with cystic fibrosis
    M Robinson
    Respiratory Investigation Unit, Royal Prince Alfred Hospital, Sydney, Australia
    J Aerosol Med 13:73-86. 2000
    ....
  3. ncbi request reprint Mucociliary clearance in cystic fibrosis
    Michael Robinson
    Cystic Fibrosis Centre E11S, Royal Prince Alfred Hospital, Missenden Road, Camperdown, New South Wales 2050, Australia
    Pediatr Pulmonol 33:293-306. 2002
    ..A number of physical and pharmacological therapies have been developed to promote mucus clearance from the CF airway. A summary of the results of interventional studies utilizing the measurement of MCC as an outcome measure is presented...
  4. ncbi request reprint Glycosylation of sputum mucins is altered in cystic fibrosis patients
    Benjamin L Schulz
    Proteome Systems Ltd, Unit 1, 35 41 Waterloo Road, North Ryde, Sydney, NSW 2113, Australia
    Glycobiology 17:698-712. 2007
    ..Sputum mucin glycosylation and degradation are therefore not inherently different in CF, and may also be useful predictive biomarkers of lung condition...
  5. ncbi request reprint A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis
    Mark R Elkins
    Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia
    N Engl J Med 354:229-40. 2006
    ..Inhaled hypertonic saline acutely increases mucociliary clearance and, in short-term trials, improves lung function in people with cystic fibrosis. We tested the safety and efficacy of inhaled hypertonic saline in a long-term trial...
  6. ncbi request reprint Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: a pilot study in a Sydney clinic
    Rajeev Soni
    Department of Respiratory Medicine, Gosford Hospital, Gosford, New South Wales, Australia
    Respirology 7:241-5. 2002
    ..cepacia and to evaluate the efficacy of the Royal Prince Alfred Hospital segregation policy. A secondary aim was to characterize the specific genomovars and strains of B. cepacia isolated in an Australian clinic...
  7. pmc Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions
    Dominic Hill
    Department of Infectious Diseases and Immunology, University of Sydney, Sydney, Australia
    J Clin Microbiol 43:5085-90. 2005
    ..The findings of this study illustrate that antibiotic sensitivities are dependent on culture conditions and highlight the complexities of choosing appropriate combination therapy for multidrug-resistant P. aeruginosa in the CF lung...
  8. ncbi request reprint Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects
    Andrew J Sloane
    Proteome Systems Ltd, Unit 1, 35 41 Waterloo Road, North Ryde, Sydney, NSW 2113, Australia
    Am J Respir Crit Care Med 172:1416-26. 2005
    ..Early diagnosis of exacerbations by rapid noninvasive means should expedite therapeutic intervention, thereby minimizing lung damage...
  9. ncbi request reprint Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction
    Evangelia Daviskas
    Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia
    J Aerosol Med 15:331-41. 2002
    ..5%) was significantly increased compared to their respective controls (18.6 +/- 3.8% and 20.9 +/- 3.6%). These preliminary results suggest that long-term treatment with HS or mannitol may benefit patients with mucociliary dysfunction...
  10. ncbi request reprint An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: application to cystic fibrosis
    Susanne K Pedersen
    Proteome Systems Ltd, 1 35 41 Waterloo Road, North Ryde, New South Wales 2113, Australia
    Mol Cell Proteomics 4:1052-60. 2005
    ....
  11. pmc Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients
    Mario Anthony
    Department of Infectious Diseases, Faculty of Medicine, University of Sydney, Australia
    J Clin Microbiol 40:2772-8. 2002
    ..This is the first study of genetic variation in P. aeruginosa isolates from adult Australian CF patients. The findings highlight the need for further investigations on the transmissibility of P. aeruginosa in CF patients...
  12. pmc Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics
    David Armstrong
    J Clin Microbiol 41:2266-7. 2003
  13. ncbi request reprint National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
    Alexandra H Filipovich
    Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio 45229, USA
    Biol Blood Marrow Transplant 11:945-56. 2005
    ..It is currently recommended that systemic therapy be considered for patients who meet criteria for chronic GVHD of moderate to severe global severity...
  14. ncbi request reprint Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report
    Steven Z Pavletic
    National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1203, USA
    Biol Blood Marrow Transplant 12:252-66. 2006
    ..The proposed response criteria are based on current expert consensus opinion and are intended to improve consistency in the conduct and reporting of chronic GVHD trials, but their use remains to be demonstrated in practice...
  15. ncbi request reprint A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis
    Janine A Smith
    National Eye Institute, NIH, Bethesda, Maryland, USA
    Arthritis Rheum 53:18-23. 2005
    ..To investigate the safety and efficacy of etanercept in the treatment of uveitis associated with juvenile idiopathic arthritis (JIA)...